Cost-effectiveness of initial therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to treat hypercholesterolemia in a primary care setting of a …
ME Spearman, K Summers, V Moore, R Jacqmin… - Clinical …, 1997 - Elsevier
From January 1994 through May 1995, Prudential HealthCare—North Texas prospectively
studied 299 member patients diagnosed with hypercholesterolemia for whom
pharmacotherapy with one of four 3-hydroxy-3-methylglutaryl coenzyme A reductase
inhibitors, also known as statins, was prescribed. The purpose of this study was to measure
the relative cost-effectiveness (CE) of these drugs in a real-world setting. This study provides
information to assist decision makers in managed-care organizations (MCO) in making …
studied 299 member patients diagnosed with hypercholesterolemia for whom
pharmacotherapy with one of four 3-hydroxy-3-methylglutaryl coenzyme A reductase
inhibitors, also known as statins, was prescribed. The purpose of this study was to measure
the relative cost-effectiveness (CE) of these drugs in a real-world setting. This study provides
information to assist decision makers in managed-care organizations (MCO) in making …
以上显示的是最相近的搜索结果。 查看全部搜索结果